Abstract: Objective It is well established that glutamate and its receptors, particularly the N-methyl-D-aspartate receptor (NMDAR), play a signifi cant role in addiction and that the inhibition of glutamatergic hyperfunction reduces addictive behaviors in experimental animals. Specifi cally, NMDAR antagonists such as MK-801, and an inducer of the expression of glutamate transporter subtype-1 (GLT-1) (ceftriaxone) are known to inhibit addictive behavior. The purpose of this study was to determine whether the combined action of a low dose of MK-801 and a low dose of ceftriaxone provides better inhibition of the acquisition, extinction, and reinstatement of morphine-induced conditioned place preference (CPP) than either compound alone. Methods A morphine-paired CPP experiment was used to study the effects of low doses of MK-801, ceftriaxone and a combination of both on reward-related memory (acquisition, extinction, and reinstatement of morphine preference) in rats. Results A low dose of neither MK-801 (0.05 mg/kg, i.p.) nor ceftriaxone (25 mg/kg, i.p.) alone effectively impaired CPP behaviors. However, when applied in combination, they reduced the acquisition of morphine-induced CPP and completely prevented morphine reinstatement. Their combination also notably impaired the extinction of morphine-induced CPP. Conclusion The combined action of a low dose of an NMDAR antagonist and GLT-1 activation by ceftriaxone effectively changed different phases of CPP behavior.
Introduction
In psychiatry, drug addiction is classifi ed as the development of compulsive drug use and drug-seeking behaviors that have progressed from a patient's voluntary drug 
Place conditioning apparatus and procedure CPP
was performed in a conventional apparatus [11] period of each day according to the previously described methods [2] . On pre-conditioning trial days (days 1-3), each animal was placed into the grey connecting compartment to freely explore the whole apparatus for 15 min. On day 3, the time spent in each conditioning compartment was recorded and animals that displayed a preference for either compartment were excluded. Then, during the conditioning phase, and reinstatement phases. Twenty-four hours after the last conditioning session, the acquisition of morphine-induced CPP was measured under conditions identical to those described for preconditioning. During morphine extinction, the animals received daily CPP training without prior morphine administration. The animals were then given free access to both compartments for 15 min on consecutive days until the time spent in the drug-paired compartment minus use [1] . For many drug addicted patients, even after extended abstinence, there exists a level of vulnerability to relapse into drug abuse [2] . For example, addicted individuals have conditioned behavioral responses to repeated environmental and drug-related cues or stimuli, such as the context of where drugs of abuse are administered. These responses to external exposures refl ect associative learning processes in the brain [3] . Therefore, one important learning mechanism that leads to drug addiction is the development of a strong preference for a drug cue, leading to drug-craving and drug-seeking responses [4] .
Previous research has shown that the neurotransmitter glutamate and its direct actions within the mammalian central nervous system play an important role in the addiction process [4] . Specifically, the N-methyl-D-aspartate receptor (NMDAR) located on the postsynaptic membrane has been implicated in learning, memory and drug addiction [5] .
NMDAR signaling depends, in part, on the extracellular concentration of glutamate, which is regulated by diffusion away from the synaptic cleft and uptake by surrounding glia via glutamate transporter-1 (GLT-1, a sodium-dependent transporter). This leads to a decrease in the level of glutamate in the synaptic cleft and attenuation of its effects [2] .
All told, these mechanisms regulate glutamate function, including the activation/inhibition of the glutamate system as it pertains to drug addiction.
For example, glutamatergic hyperfunction in the nucleus accumbens and prefrontal cortex has been found during the reinstatement of morphine-induced conditioned place preference (CPP) [6] . Conversely, inhibition of glutamate system function by MK-801, a non-competitive NMDAR antagonist, reduces morphine-induced CPP and sensitization [7, 8] . In addition, the level of GLT-1 is decreased in addictive states [9] . Interestingly, ceftriaxone, a β-lactam antibiotic, attenuates the development of addictive behaviors by inducing GLT-1 expression and removing excess glutamate from the synaptic cleft [10] .
Therefore, the present study was conducted to test whether a low dose of MK-801 in combination with ceftriaxone effectively inhibits the glutamate system and alleviates addictive behaviors.
Yaodong Fan, et al. MK-801 combined with ceftriaxone attenuates morphine-induced CPP in rats 569 that for the vehicle compartment was similar to that of the pre-conditioning phase (day 3) [2] . Morphine reinstatement was measured by giving rats a priming injection of morphine (2.0 mg/kg) 15 min prior to placing them in the CPP apparatus with free access to both sides [12] . The amount of time spent in each conditioning compartment was recorded as a measure of CPP for each phase. determined from previous studies with these drugs [10, 13] .
Following the eight conditioning sessions, the rats were tested for morphine-induced CPP as described above (Fig.   1A ). . In all experiments, the preference for a chamber was scored as described below. 2.4 Statistical analysis CPP data were calculated as: time spent in drug-paired chamber/sum of time spent in both chambers [5] . has been used as a model [14] . Furthermore, the priming injection had no effect on saline-trained rats. The results of the post hoc analysis showed that pre-treatment with neither MK-801 nor ceftriaxone had an effect on the reinstatement of the CPP primed by morphine. However, pretreatment with a combination of both MK-801 and ceftriaxone blocked the reinstatement by morphine priming (P <0.05). 
Experiment

Combined action of MK-
Discussion
The results of the present study showed that neither a Although previous reports on MK-801 (0.5 mg/kg) [15] and ceftriaxone (100 and 200 mg/kg) [10, 16] found that each agent inhibits addictive behaviors in, for example, the CPP paradigm, our study aimed to assess the interaction between the two agents and their ability to inhibit CPP development. Our preliminary experiments (unpublished data) used three doses of MK-801 (0.05, 0.1, and 0.5 mg/kg) and ceftriaxone (25, 100, and 200 mg/kg) to determine the doses most appropriate for exploring their relationship.
In order to avoid a ceiling effect, the lowest dose of each agent was used to investigate their interaction.
As expected, the administration of morphine (10 mg/kg) to rats produced CPP behavior similar to our previous re- 574 sults [17] . Morphine is thought to inhibit inhibitory γ-aminobutyric acid (GABAergic) interneurons, thereby increasing dopamine signaling to the nucleus accumbens [18] . However, dopaminergic neurons in the mesolimbic system receive projections from both GABAergic and glutamatergic neurons in the prefrontal cortex, amygdala, hippocampus, and subthalamic nuclei in the rat [19, 20] . Therefore, disruption of the glutamate system must also have a considerable effect on the reward contribution of morphine. For example, the NMDAR antagonist AP5 (0.48 nmol/0.3 μL) blocks the acquisition of morphine-induced CPP when delivered directly into the ventral tegmental area immediately before morphine conditioning [21] . There is also evidence that glutamate transmission in key neuronal circuits plays a critical role in the initiation and acquisition of addiction-related behaviors [22] . Furthermore, a previous study reported that MK-801 (1.0 mg/kg) impairs the acquisition of morphineinduced CPP by inhibiting dopaminergic activation mediated through the NMDAR [8] . In another study, repeated ceftriaxone administration (200 mg/kg) reduced the ability to acquire cocaine dependency and limited the motivation to self-administer cocaine by reducing direct reinforcing behaviors [11] . However, here we used considerably lower doses to determine whether the combined action of MK-801 and ceftriaxone were able to inhibit the acquisition, extinction, and reinstatement of morphine-induced CPP.
Although we found that a low dose of MK-801 or cef- It is also notable that other evidence suggests that glutamate transmission plays a critical role in the expression of addiction-related behaviors, including drug-seeking [22] .
For example, glutamate-induced activation of neurons in the ventral tegmental area reinstated morphine-induced CPP [23] . Furthermore, chronic morphine treatment downregulated GLT-1, subsequently increasing the extracellular levels of glutamate [24] which further implicates the glutamate system in the addiction process. In an attempt to reduce the infl uence of glutamate on the addiction-like CPP behaviors towards morphine, ceftriaxone, a B-lactam antibiotic known to elevate GLT-1 expression via nuclear factor-κB and to decrease the level of extracellular glutamate [9] , and MK-801, an NMDAR antagonist, were used to inhibit the function of the glutamate system by decreasing extracellular glutamate levels and inhibiting glutamate signaling. Notably, the combined action of MK-801 and ceftriaxone had a considerably stronger effect in inhibiting the morphine-induced hyperfunction of the glutamate system during reinstatement in comparison to the null effects shown by each agent alone.
Interestingly, the extinction of morphine-induced CPP was delayed/impaired in the rats treated with a combination of MK-801 and ceftriaxone, which supports the notion that extinction is a learning and memory process that involves the glutamate system [11] . However, the molecular mechanism is not completely understood. Some evidence links glutamate NMDARs to the transition and/or consolidation of learned fear-paired memory cues to the extinction of these associated cues. For example, rats given NMDAR antagonists can learn extinction traits, but fail to retain long-term memory of the extinction process [25] .
Furthermore, NMDAR antagonists directly delivered to the amygdala impair extinction learning during fear conditioning [9] . It has been suggested that NMDAR antagonists block NMDA-dependent calcium signaling and the subsequent molecular cascades that lead to the formation of long-term memory [26] . These descriptions collectively suggest that inhibiting the glutamate system is likely to impair learning and memory. However, the fi nding that the combined action of the agents used here to inhibit the glutamate system delayed the extinction of morphine-paired reward cues suggests that the combination strengthened the memory of the morphine cue.
All told, the low doses of MK-801, ceftriaxone, and their combination were not found to induce CPP behaviors specific to these agents alone. Furthermore, these agents
were not found to have deleterious effects on the motor activity of the rats. These fi ndings suggest that no reward or 
